These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 4968322)

  • 1. Clinical trial of live attenuated rubella virus vaccine, HPV-77 strain.
    Cooper LZ; Giles JP; Krugman S
    Am J Dis Child; 1968 Jun; 115(6):655-7. PubMed ID: 4968322
    [No Abstract]   [Full Text] [Related]  

  • 2. A trial with live attenuated rubella vaccine.
    Lepow ML; Veronelli JA; Hostetler DD; Robbins FC
    Am J Dis Child; 1968 Jun; 115(6):639-47. PubMed ID: 4968320
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical studies with experimental live rubella virus vaccine (strain HPV-77). Evaluation of vaccine-induced immunity.
    Meyer HM; Parkman PD; Hobbins TE; Ennis FA
    Am J Dis Child; 1968 Jun; 115(6):648-54. PubMed ID: 4968321
    [No Abstract]   [Full Text] [Related]  

  • 4. Vaccination of infants with HPV-77 vaccine.
    Pavilanis V; Chagnon A; Davignon L; Joncas J
    Am J Dis Child; 1969 Aug; 118(2):247-51. PubMed ID: 4978509
    [No Abstract]   [Full Text] [Related]  

  • 5. Experimental active and passive immunization against rubella.
    Budai J; Tóth M; Melis L
    Acta Paediatr Acad Sci Hung; 1970; 11(3):209-17. PubMed ID: 4111953
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical trials of RA 27-3 (Wistar) rubella vaccine in Japan.
    Furukawa T; Miyata T; Kondo K; Kuno K; Isomura S; Takekoshi T
    Am J Dis Child; 1969 Aug; 118(2):262-3. PubMed ID: 4978510
    [No Abstract]   [Full Text] [Related]  

  • 7. Attenuated rubella viruses. Laboratory and clinical characteristics.
    Meyer HM; Parkman PD; Hobbins TE; Larson HE; Davis WJ; Simsarian JP; Hopps HE
    Am J Dis Child; 1969 Aug; 118(2):155-65. PubMed ID: 4978508
    [No Abstract]   [Full Text] [Related]  

  • 8. Live attenuated rubella virus vaccines in young adult women. Trials of Cendehill and HPV-77 DE-5.
    Byrne EB; Ryan JM; Randolph MF; Horstmann DM
    Am J Dis Child; 1969 Aug; 118(2):234-6. PubMed ID: 4183351
    [No Abstract]   [Full Text] [Related]  

  • 9. Production of rubella virus vaccine. Live, attenuated in canine renal cell cultures.
    Musser SJ; Hilsabeck LJ
    Am J Dis Child; 1969 Aug; 118(2):355-61. PubMed ID: 4978513
    [No Abstract]   [Full Text] [Related]  

  • 10. A study of rubella immunity and resistance to infection.
    Davis WJ; Larson HE; Simsarian JP; Parkman PD; Meyer HM
    JAMA; 1971 Jan; 215(4):600-8. PubMed ID: 5107436
    [No Abstract]   [Full Text] [Related]  

  • 11. Reinfection with rubella virus despite live vaccine induced immunity. Trials of HPV-77 and HPV-80 live rubella virus vaccines and subsequent artificial and natural challenge studies.
    Wilkins J; Leedom JM; Portnoy B; Salvatore MA
    Am J Dis Child; 1969 Aug; 118(2):275-94. PubMed ID: 5794818
    [No Abstract]   [Full Text] [Related]  

  • 12. Live, attenuated rubella-virus vaccine.
    Hilleman MR; Buynak EB; Weibel RE; Stokes J
    N Engl J Med; 1968 Aug; 279(6):300-3. PubMed ID: 4969117
    [No Abstract]   [Full Text] [Related]  

  • 13. Prospects for a rubella virus vaccine.
    Parkman PD; Meyer HM
    Prog Med Virol; 1969; 11():80-106. PubMed ID: 4984711
    [No Abstract]   [Full Text] [Related]  

  • 14. Artificial challenge studies in rubella. Utilization of RA 27-3 rubella vaccines, rubella naturally acquired seropositives, and rubella susceptible children.
    Naficy K; Nategh R; Ahangary S; Mohsenin H
    Am J Dis Child; 1970 Dec; 120(6):520-3. PubMed ID: 5481902
    [No Abstract]   [Full Text] [Related]  

  • 15. Live attenuated rubella virus vaccines prepared in duck embryo cell culture. I. Development and clinical testing.
    Buynak EB; Hilleman MR; Weibel RE; Stokes J
    JAMA; 1968 Apr; 204(3):195-200. PubMed ID: 4172467
    [No Abstract]   [Full Text] [Related]  

  • 16. Live attenuated rubella virus vaccines. Experiences with duck embryo cell preparations.
    Hilleman MR; Buynak EB; Whitman JE; Weibel RW; Stokes J
    Am J Dis Child; 1969 Aug; 118(2):166-71. PubMed ID: 5815860
    [No Abstract]   [Full Text] [Related]  

  • 17. Further studies of an attenuated rubella strain grown in WI-38 cells.
    Plotkin SA; Farquhar JD; Katz M; Hertz C
    Am J Epidemiol; 1969 Feb; 89(2):232-8. PubMed ID: 5765961
    [No Abstract]   [Full Text] [Related]  

  • 18. Immunogenicity and reactogenicity of live attenuated rubella virus vaccines.
    Andzhaparidze OG; Desyatskova RG; Chervonski GI; Pryanichnikova LV
    Am J Epidemiol; 1970 May; 91(5):527-30. PubMed ID: 5462118
    [No Abstract]   [Full Text] [Related]  

  • 19. Viral shedding in Chinese children following vaccination with HPV-77 and Cendehill-51 live attenuated rubella vaccines.
    Detels R; Kim KS; Gale JL; Grayston JT
    Am J Epidemiol; 1971 Nov; 94(5):473-8. PubMed ID: 4941155
    [No Abstract]   [Full Text] [Related]  

  • 20. An attenuated rubella virus vaccine (Cendehill 51 strain) grown in primary rabbit kidney cells.
    Huygelen C; Peetermans J; Prinzie A
    Prog Med Virol; 1969; 11():107-25. PubMed ID: 4984707
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.